España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Intellia Therapeutics
NTLA
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$13.97
-1.15
-7.61%
At close: -
$14.05
0.08
0.57%
After Hours: 7:45 PM EDT
Get Report
Comment
Intellia Therapeutics (NTLA) Forecast
News
Earnings
Intellia Therapeutics (NTLA) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Government Trades
Short Interest
Latest news for Intellia Therapeutics (NASDAQ:NTLA) Stock
Intellia Therapeutics Stock (NASDAQ: NTLA)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Monday, November 11, 2024
9 Analysts Have This To Say About Intellia Therapeutics
Benzinga Insights
Oppenheimer Maintains Outperform on Intellia ...
Benzinga Newsdesk
Friday, November 08, 2024
Barclays Maintains Overweight on Intellia The...
Benzinga Newsdesk
Thursday, November 07, 2024
Intellia Ended The Third Quarter Of 2024 With...
Benzinga Newsdesk
Intellia Therapeutics Q3 2024 GAAP EPS $(1.34...
Benzinga Newsdesk
Wednesday, November 06, 2024
A Glimpse of Intellia Therapeutics's Earnings Potential
Benzinga Insights
Tuesday, October 29, 2024
Looking Into Intellia Therapeutics's Recent Short Interest
Benzinga Insights
Friday, October 25, 2024
Goldman Sachs Maintains Neutral on Intellia T...
Benzinga Newsdesk
7 Analysts Have This To Say About Intellia Therapeutics
Benzinga Insights
Baird Maintains Neutral on Intellia Therapeut...
Benzinga Newsdesk
Monopar Therapeutics, Intellia Therapeutics, Capri Holdings, Western Digital, And Tesla: Why These 5 Stocks Are On Investors' Radars Today
Benzinga Neuro
Thursday, October 24, 2024
Chardan Capital Maintains Buy on Intellia The...
Benzinga Newsdesk
A Closer Look at Intellia Therapeutics's Options Market Dynamics
Benzinga Insights
Why Is Gene Therapy-Focused Intellia Therapeutics Stock Trading Lower On Thursday?
Vandana Singh
3 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights
Intellia Reports Positive Phase 2 Results For...
Benzinga Newsdesk
Monday, October 07, 2024
Intellia Therapeutics Has Initiated HAELO Pha...
Benzinga Newsdesk
Tuesday, October 01, 2024
Intellia to Present CRISPR Therapy Data for H...
Benzinga Newsdesk
Thursday, September 19, 2024
RBC Capital Reiterates Outperform on Intellia...
Benzinga Newsdesk
Tuesday, September 17, 2024
Jones Trading Initiates Coverage On Intellia ...
Benzinga Newsdesk
Reported Thursday September 12, 2024, Intelli...
Benzinga Newsdesk
Wednesday, September 11, 2024
Expert Outlook: Intellia Therapeutics Through The Eyes Of 7 Analysts
Benzinga Insights
Stifel Maintains Buy on Intellia Therapeutics...
Benzinga Newsdesk
Monday, August 12, 2024
Expert Ratings For Intellia Therapeutics
Benzinga Insights
JP Morgan Maintains Overweight on Intellia Th...
Benzinga Newsdesk
Friday, August 09, 2024
RBC Capital Maintains Outperform on Intellia ...
Benzinga Newsdesk
Thursday, August 08, 2024
Intellia Therapeutics Cash, Cash Equivalents ...
Benzinga Newsdesk
Intellia Therapeutics Q2 2024 GAAP EPS $(1.52...
Benzinga Newsdesk
Tuesday, July 30, 2024
Intellia Therapeutics Receives UK MHRA Author...
Benzinga Newsdesk
Intellia Therapeutics Receives Authorization ...
Benzinga Newsdesk
Friday, July 12, 2024
Bank of New York Mellon Posts Upbeat Earnings, Joins Archer Aviation, Rivian Automotive And Other Big Stocks Moving Higher On Friday
Avi Kapoor
Thursday, July 04, 2024
Cathie Wood's Ark Invest Dumps Another $3.25M Worth Of Tesla Shares Amid Searing Q2 Deliveries Rally
Benzinga Neuro
Wednesday, July 03, 2024
Cathie Wood's Ark Invest Sells Tesla Shares Worth $14.5M Amid Rally Driven By Q2 Delivery Numbers, Picks Up Palantir Shares Again Today
Benzinga Neuro
Thursday, June 27, 2024
Canaccord Genuity Maintains Buy on Intellia T...
Benzinga Newsdesk
Cathie Wood's Ark Invest Acquires $7.3M Worth Of Shares In This Promising Netflix Competitor, Sells Off Coinbase Stock Amid Bitcoin Slump
Benzinga Neuro
Wednesday, June 26, 2024
Intellia Therapeutics Named Edward Dulac Of F...
Benzinga Newsdesk
Tuesday, June 25, 2024
Intellia Therapeutics Presents Data On Redosi...
Benzinga Newsdesk
Monday, June 24, 2024
Cantor Fitzgerald Reiterates Overweight on In...
Benzinga Newsdesk
Unveiling 6 Analyst Insights On Intellia Therapeutics
Benzinga Insights
Truist Securities Maintains Buy on Intellia T...
Benzinga Newsdesk
RXO, Alnylam Pharmaceuticals And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Avi Kapoor
5 Biotech Stocks With Key Catalysts This Week: Merck, Intellia, Verona, And More
Shanthi Rexaline
Thursday, June 20, 2024
Behind the Scenes of Intellia Therapeutics's Latest Options Trends
Benzinga Insights
Tuesday, June 18, 2024
Cantor Fitzgerald Reiterates Overweight on In...
Benzinga Newsdesk
Monday, June 17, 2024
Intellia Therapeutics Announced The Acceptanc...
Benzinga Newsdesk
Sunday, June 16, 2024
Avidity Biosciences And CleanSpark Were Among The 10 Biggest Mid-Cap Stock Gainers Last Week (June 9-June 15): Are These In Your Portfolio?
Lekha Gupta
Tuesday, June 11, 2024
Cathie Wood-Lead Ark Invest Dumps $7.6M Worth Of Robinhood Shares Amid GameStop Buzz, Bitcoin Choppiness
Benzinga Neuro
Friday, June 07, 2024
Cathie Wood-Led Ark Invest Buys $9.9M Worth Of Amazon Shares, Also Picks Up Reddit Stock
Benzinga Neuro
Tuesday, June 04, 2024
Cracking The Code: Understanding Analyst Reviews For Intellia Therapeutics
Benzinga Insights
Intellia Up on Upbeat Long-Term Angioedema Study Data
Zacks
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch